Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Cerilliant
Express Scripts
AstraZeneca
McKinsey
Federal Trade Commission
Colorcon
Healthtrust

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,870,105

« Back to Dashboard

Summary for Patent: 4,870,105
Title: Phosphorus binder
Abstract:A composition for oral administration to an individual for the purpose of inhibiting gastrointestinal absorption of phosphorous, which includes calcium acetate. A method of inhibiting gastrointestinal absorption of phosphorous, comprising administering orally the composition, preferably close in time to food and beverage consumption.
Inventor(s): Fordtran; John S. (Dallas, TX)
Assignee: Braintree Laboratories, Inc. (Braintree, MA)
Application Number:07/035,341
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,870,105
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 4,870,105

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,870,105

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1333884 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Medtronic
Fish and Richardson
Boehringer Ingelheim
Federal Trade Commission
AstraZeneca
Citi
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.